白血病抑制因子(LIF)單克隆抗體
Monoclonal Antibody to Leukemia Inhibitory Factor (LIF)
CDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
- 編號UMAA085Hu22
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C1
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA085Hu01-白血病抑制因子(LIF)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 261 ¥ 609 ¥ 870 ¥ 2175 ¥ 8700
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Pancreas Tissue; Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Samples: Human Small intestine Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Samples: Human Skeletal muscle Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Figure. Western Blot; Sample: Recombinant LIF, Human.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對LIF的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別LIF。
用法
Western blotting: 0.5-3μg/mL;
Immunohistochemistry: 5-30μg/mL;
Immunocytochemistry: 5-30μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPA085Hu61 | 白血病抑制因子(LIF)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA085Hu01 | 白血病抑制因子(LIF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA085Hu61 | 白血病抑制因子(LIF)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA085Hu01 | 白血病抑制因子(LIF)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAA085Hu01 | 白血病抑制因子(LIF)多克隆抗體 | WB; IHC |
| UMAA085Hu22 | 白血病抑制因子(LIF)單克隆抗體 | IHC |
| UMAA085Hu21 | 白血病抑制因子(LIF)單克隆抗體 | IHC; ICC/IF |
| UMAA085Hu23 | 白血病抑制因子(LIF)單克隆抗體 | IHC |
| UMAA085Hu24 | 白血病抑制因子(LIF)單克隆抗體 | IHC |
| USEA085Hu | 白血病抑制因子(LIF)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA085Hu | 白血病抑制因子(LIF)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| British?Journal of Anaesthesia | Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids [pubmed:28077540] |
| Biological Rhythm Research | A study of altered cytokine rhythms associated with successful implantation in cows [10.1080/09291016.2017.1361159] |
| Integrated analysis of cancer stem cells-associated lncRNA-miRNA-mRNA network for ovarian cancer via microarray and Gene Expression Omnibus database [] |
留言咨詢
